BSX – Boston Scientific Corporation
Float Short %
1.91
Margin Of Safety %
7
Put/Call OI Ratio
0.35
EPS Next Q Diff
EPS Last/This Y
EPS This/Next Y
0.45
Price
74.57
Target Price
104.52
Analyst Recom
1.25
Performance Q
-24.83
Upside
-42.8%
Beta
0.7
Ticker: BSX
of 1
| Date | Symbol | Latest | P/C OI | P/C Vol | Total OI |
|---|---|---|---|---|---|
| 2026-01-23 | BSX | 92.45 | 0.60 | 0.41 | 345842 |
| 2026-01-26 | BSX | 93.52 | 0.58 | 0.36 | 355199 |
| 2026-01-27 | BSX | 93.6 | 0.57 | 0.94 | 362007 |
| 2026-01-28 | BSX | 93.8 | 0.58 | 1.18 | 363738 |
| 2026-01-29 | BSX | 92.33 | 0.60 | 0.26 | 369988 |
| 2026-01-30 | BSX | 93.55 | 0.59 | 0.39 | 373837 |
| 2026-02-02 | BSX | 91.85 | 0.60 | 0.08 | 357103 |
| 2026-02-04 | BSX | 75.45 | 0.53 | 0.70 | 402514 |
| 2026-02-05 | BSX | 77.64 | 0.51 | 0.33 | 442570 |
| 2026-02-06 | BSX | 76.27 | 0.46 | 0.69 | 480738 |
| 2026-02-09 | BSX | 74.26 | 0.46 | 2.06 | 470096 |
| 2026-02-10 | BSX | 74.25 | 0.39 | 0.17 | 450322 |
| 2026-02-11 | BSX | 73.6 | 0.37 | 0.46 | 459006 |
| 2026-02-12 | BSX | 74.12 | 0.36 | 3.30 | 457086 |
| 2026-02-13 | BSX | 74.76 | 0.35 | 0.18 | 463460 |
| 2026-02-18 | BSX | 76.26 | 0.35 | 0.21 | 465846 |
| 2026-02-19 | BSX | 75.67 | 0.35 | 0.61 | 472589 |
| Date | Symbol | Latest | P/C OI | P/C Vol | Total OI |
Current Page1 of 1
of 1
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
|---|---|---|---|---|---|
| 2026-01-23 | BSX | 92.53 | 11.6 | 2834.7 | 3.03 |
| 2026-01-26 | BSX | 93.55 | 11.6 | 2821.3 | 3.03 |
| 2026-01-27 | BSX | 93.60 | 11.6 | 2758.1 | 3.03 |
| 2026-01-28 | BSX | 93.72 | 11.6 | 2762.2 | 3.03 |
| 2026-01-29 | BSX | 92.21 | 11.6 | 2655.8 | 3.03 |
| 2026-01-30 | BSX | 93.57 | 11.6 | 2833.9 | 3.03 |
| 2026-02-02 | BSX | 91.85 | 11.6 | 2648.9 | 3.03 |
| 2026-02-03 | BSX | 91.58 | 11.6 | 2736.7 | 3.03 |
| 2026-02-04 | BSX | 75.43 | 11.6 | 1712.7 | 3.03 |
| 2026-02-05 | BSX | 77.64 | 11.6 | 2919.9 | 3.03 |
| 2026-02-06 | BSX | 76.26 | 11.6 | 2652.1 | 3.03 |
| 2026-02-09 | BSX | 74.12 | 5.2 | 2575.6 | 3.46 |
| 2026-02-10 | BSX | 74.25 | 5.8 | 2749.5 | 3.46 |
| 2026-02-12 | BSX | 74.12 | 5.7 | 2790.1 | 3.46 |
| 2026-02-18 | BSX | 76.26 | 5.8 | 2736.7 | 3.46 |
| 2026-02-19 | BSX | 75.70 | 5.8 | 2694.9 | 3.46 |
| 2026-02-20 | BSX | 74.57 | 5.8 | - | 3.46 |
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
Current Page1 of 1
of 1
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
|---|---|---|---|---|
| 2026-01-23 | BSX | -4.42 | 0.42 | 1.35 |
| 2026-01-26 | BSX | -4.42 | 0.17 | 1.35 |
| 2026-01-27 | BSX | -4.42 | 0.17 | 1.35 |
| 2026-01-28 | BSX | -4.42 | 0.17 | 1.59 |
| 2026-01-29 | BSX | -4.35 | 0.17 | 1.59 |
| 2026-01-30 | BSX | -4.35 | 0.17 | 1.59 |
| 2026-02-02 | BSX | -4.31 | 0.36 | 1.59 |
| 2026-02-03 | BSX | -6.79 | 0.36 | 1.59 |
| 2026-02-04 | BSX | -6.79 | 0.36 | 1.59 |
| 2026-02-05 | BSX | -5.77 | 0.36 | 1.59 |
| 2026-02-06 | BSX | -5.77 | 0.36 | 1.59 |
| 2026-02-09 | BSX | -5.91 | 0.69 | 1.58 |
| 2026-02-10 | BSX | -5.91 | 0.69 | 1.58 |
| 2026-02-11 | BSX | -5.91 | 0.69 | 1.91 |
| 2026-02-12 | BSX | -5.91 | 0.69 | 1.91 |
| 2026-02-13 | BSX | -5.91 | 0.69 | 1.91 |
| 2026-02-17 | BSX | -5.91 | 0.57 | 1.91 |
| 2026-02-18 | BSX | -5.77 | 0.57 | 1.91 |
| 2026-02-19 | BSX | -5.77 | 0.57 | 1.91 |
| 2026-02-20 | BSX | -5.76 | 0.57 | 1.91 |
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
Current Page1 of 1
Last Quarter Act. EPS
Avg. EPS Est. Current Quarter
0.79
Avg. EPS Est. Next Quarter
0.87
Insider Transactions
-5.76
Institutional Transactions
0.57
Beta
0.7
Average Sales Estimate Current Quarter
5190
Average Sales Estimate Next Quarter
5566
Fair Value
80
Quality Score
89
Growth Score
95
Sentiment Score
54
Actual DrawDown %
31.9
Max Drawdown 5-Year %
-32.1
Target Price
104.52
P/E
38.46
Forward P/E
19.01
PEG
1.44
P/S
5.51
P/B
4.56
P/Free Cash Flow
30.25
EPS
1.94
Average EPS Est. Cur. Y
3.46
EPS Next Y. (Est.)
3.92
Target Price Estimates Raised
Target Price Estimates Lowered
1
Profit Margin
14.44
Relative Volume
0.94
Return on Equity vs Sector %
-17.1
Return on Equity vs Industry %
-5.8
EPS 1 7Days Diff
EPS 1 30Days Diff
-0.01
EBIT Estimation
Boston Scientific CorporationSector: Healthcare
Industry: Medical Devices
Employees: 59000
Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. The company operates in two segments, MedSurg and Cardiovascular. It offers devices to diagnose and treat a range of gastrointestinal conditions, such as resolution clips, biliary stent systems, stents and electrocautery enhanced delivery systems, SpyGlass, single-use scopes used for diagnostic and therapeutic procedures in the pancreaticobiliary system, in endoscopic retrograde cholangiopancreatography procedures, and single-use duodenoscopes, as well as endoluminal surgery and infection prevention products; devices to treat urological conditions, including ureteral stents, catheters, baskets, guidewires, urinary and bowel dysfunction, sheaths, balloons, single-use digital flexible ureteroscopes, holmium laser systems, penile implants, artificial urinary sphincter, laser system, and hydrogel systems; and devices to treat neurological movement disorders and manage chronic pain, such as spinal cord stimulator systems, radiofrequency ablation, and intraosseous nerve ablation and deep brain stimulation systems. The company also provides technologies for diagnosing and treating a range of diseases and abnormalities of the heart; WATCHMAN FLX, a left atrial appendage closure (LAAC) device; and implantable devices that monitor the heart and deliver electricity to treat cardiac abnormalities, such as cardioverter and cardiac resynchronization therapy defibrillators, MRI S-ICD systems, cardiac resynchronization therapy pacemakers, remote patient management systems, insertable cardiac monitor systems, and remote cardiac monitoring systems. In addition, it offers diagnosis and treatment of rate and rhythm disorders of the heart; peripheral arterial and venous diseases; and products to diagnose and treat forms of cancer. The company was incorporated in 1979 and is headquartered in Marlborough, Massachusetts.
stock quote shares BSX – Boston Scientific Corporation Stock Price stock today
news today BSX – Boston Scientific Corporation stock forecast ,stock prediction 2023 2024 2025
marketwatch BSX – Boston Scientific Corporation yahoo finance google finance
stock history BSX – Boston Scientific Corporation invest stock market
stock prices BSX premarket after hours
ticker BSX fair value insiders trading